Jade Biosciences, Inc. (JBIO)
NASDAQ: JBIO · Real-Time Price · USD
15.07
+0.97 (6.88%)
At close: Nov 6, 2026, 4:00 PM EST
15.37
+0.30 (1.99%)
After-hours: Nov 6, 2026, 6:16 PM EST
Jade Biosciences Market Cap
Jade Biosciences has a market cap or net worth of $958.41 million as of November 6, 2026. It is the 10,138th most valuable company in the world and the 2,241st biggest in the United States. Its market cap has increased by 205.99% in one year.
Market Cap
958.41M
Enterprise Value
498.60M
1-Year Change
205.99%
Global Rank
Country Rank
#2,241 United States
Category
ChartMarket Cap Chart
Since April 29, 2025, Jade Biosciences's market cap has increased from $326.87M to $958.41M, an increase of 193.21%. That is a compound annual growth rate of 102.62%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 958.41M | 35.02% |
| Dec 31, 2025 | 709.84M | 117.16% |
| Apr 29, 2025 | 326.87M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| MoonLake Immunotherapeutics | 984.26M |
| ORIC Pharmaceuticals | 969.15M |
| Rigel Pharmaceuticals | 957.53M |
| Latigo Biotherapeutics | 951.40M |
| Immatics | 943.16M |
| Syndax Pharmaceuticals | 934.94M |
| Odyssey Therapeutics | 927.22M |
| Monte Rosa Therapeutics | 921.81M |